Imagen de Portada
Código QR

HIV rapid tests: progress, perspective, and future directions.

In November 2002, the U.S. Food and Drug Administration approved the OraQuick Rapid HIV-1 Antibody Test (OraSure Technologies, Inc., Bethlehem, PA), a reliable, rapid test that detects HIV-1 antibodies. In contrast to other HIV-testing techniques, the OraQuick test uses blood obtained by finger stic...

Descripción completa

Publicado en:Clinical Journal of Oncology Nursing Vol. 7; no. 2; pp. 207 - 209
Autor principal: Burrage J Jr.
Formato: tables/charts Journal Article
Publicado: Oncology Nursing Society Mar/Apr2003
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106835024&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106835024
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10921095
        GNN
      jtl: Clinical Journal of Oncology Nursing
      issn: 10921095
      maglogo: N
    pubinfo:
      dt: Mar/Apr2003
      vid: 7
      iid: 2
      pid: 12496
      pub: Oncology Nursing Society
      place: Pittsburgh, Pennsylvania
    artinfo:
      ui:
        106835024
        106835024
        2003068660
        10.1188/03.CJON.207-208
        NLM12696218
        106835024
      ppf: 207
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: HIV rapid tests: progress, perspective, and future directions.
      aug:
        au: Burrage J Jr.
      sug:
        subj:
          AIDS Serodiagnosis Methods
          Blood Specimen Collection
          Centers for Disease Control and Prevention (U.S.)
          Counseling
          Health Services Accessibility
          Time Factors
      ab: In November 2002, the U.S. Food and Drug Administration approved the OraQuick Rapid HIV-1 Antibody Test (OraSure Technologies, Inc., Bethlehem, PA), a reliable, rapid test that detects HIV-1 antibodies. In contrast to other HIV-testing techniques, the OraQuick test uses blood obtained by finger stick instead of venipuncture and provides results in 20 minutes. Implications for practice, as well as future applications of this technology, are discussed in this article.
      pubtype: Academic Journal
      doctype:
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N